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Abstract
This study aimed to investigate in vivo two stent technologies, with particular emphasis on thrombogenicity and
inflammatory vessel remodeling processes. The micro-stents tested in this study were developed for intracranial aneurysm
treatment. In our study twelve, New Zealand white rabbits were divided into two groups: 18 laser-cut stents (LCS) and 18
braided stents (BS) were impanated without admiration of antiplatelet medication. Three stents were implanted into each
animal in the common carotid artery, subclavian artery, and abdominal aorta. Digital subtraction angiography was performed
before and after stent implantation and at follow-up for the visualization of occurring In-stent thromboembolism or stenosis.
The Stents were explanted for histopathological examination at two different timepoints, after 3 and 28 days.
Angiographically neither in-stent thrombosis nor stenosis for both groups was seen. There was a progressive increase in
the vessel diameter, which was more pronounced for BS than for LCS. We detected a higher number of thrombi adherent to
the foreign material on day 3 for BS. On day 3, the neointima was absent, whereas the complete formation observed was on
day 28. There was no significant difference between both groups regarding the thickness of the neointima. The in vivo model
of our study enabled the evaluation of blood and vessel reactions for two different stent technologies. Differences in vessel
dimension and tissue around the stents were observed on day 28. Histological analysis on day 3 enabled the assessment of
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Stent-assisted coiling of wide-necked intracranial aneur-
ysms aims to prevent coil prolapse into the parent vessel,
enhancing vessel remodelling processes. Although this
neurovascular technique has proven effective and safe in
several studies, the presence of foreign material within the
vessel lumen is associated with clinical complications.
Namely, thromboembolic events and delayed stenosis have
been reported and represent an important factor threatening
the outcome of the procedure [1–4].
A better understanding of the cellular effects of stent
design on blood and vessel reactions can potentially
contribute to both product design development and pro-
cedural planning [5, 6]. State-of-the-art implants can be
divided into two groups with regard to manufacturing and
design features: laser-cut stents (LCS) and braided stents
(BS). LCS involves removing material from a tube,
creating openings surrounded by struts that deform from
the radially compressed configuration to the expanded
configuration. In contrast, BS comprises multiple wires
interwoven into a cylindrical shape. The design of BS
reduces deformation of the wire by allowing relative
sliding between wires. The divergent manufacturing
processes result in consistent differences between both
stent technologies, particularly regarding stent elements
(squared struts in LCS vs. round wires in BS), stent
profile (thicker in BS because of crossing wires at inter-
connecting points), and radial expansion force (high in
both stents, depending on construction parameters and
size) Moreover, surface finishing is usually different in
the two technologies [7].
The present study evaluated LCS and BS in a novel
in vivo animal model, facilitating histopathological exam-
ination at subacute and mid-term follow-up, with emphasis
on vessel response and neointima formation. To the best of
our knowledge, this study represents the first in vivo com-
parison of two state-of-the-art technologies for intracranial
stents and a novel analysis of harvested stented vessels at a
subacute phase.
2 Materials and methods
2.1 Implants
Both the LCS (Acclinoflex®/Credo®) and BS (Accero®)
used in this study are clinically available (Acandis GmbH
Pforzheim, Germany) and compare the superelastic nickel
titanium alloy Nitinol©. LCS have six openings around the
circumference and a wall thickness of 50 µm. The struts
have an alternating width of 40 and 32 µm, resulting in an
asymmetrical structure for improved flexibility. Three
radiopaque markers are placed at each end. For this study,
LCS with a diameter of 4.5 mm and lengths of 15 mm or
20 mm were used.
The BS used have a diameter of 2.5 mm or 4.5 mm. The
stent comprised a 50 µm single wire bent at each end in
multiple loops, resulting in six and nine openings around
the circumference for both sizes, respectively. Implant
thickness at the wire crossing points was 100 µm. The open
wire ends were connected with a radiopaque marker in the
middle of the stent.
2.2 Animal studies
The study was approved by the University’s animal welfare
committee and conducted in accordance with the institu-
tional animal experiment guidelines. Twelve rabbits were
implanted with 36 stents, either of LCS (n= 18) or BS (n=
18) type. Because of design-specific features discernible
during the procedure, both groups were not blinded. Anti-
platelet therapy was not provided before, during, or after
stenting. The right femoral artery was surgically exposed
under general anaesthesia and a 4 F sheath inserted. A dose
of 300 U heparin was administered intravenously during the
procedure. Stents were implanted over the wire. Opening of
the markers confirmed adequate positioning and expansion.
Target vessels for stent placement are depicted in Fig. 1.
Two stents were placed in the right subclavian artery (SA)
distal to the orifice of the vertebral artery and in the left
common carotid artery (CCA), respectively. These vessels
were selected due to the small lumen diameter of ~2 mm,
representing a worst-case alignment with regard to stent
thickness/vessel lumen ratio. To provide an identical num-
ber of cells along the circumference, and, therefore, a
similar metal coverage ratio, different stent sizes were
implanted. For BS, 2.5 × 10 mm was used, which was
intended for a vessel diameter of 1.5–2.5 mm, whereas
4.5 ×15 mm was used for LCS, which was intended for a
vessel diameter of 2.5–4 mm. The stent length for BS was
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12 mm and for LS 17.7 mm in vessels with a diameter of
2 mm. The stent length increased in BS for smaller vessel
lumens (internal data), reducing the length difference
between the two stents. A third stent was implanted in the
abdominal aorta (AA) with a stent diameter of 4.5 mm for
each group and a length of 20 and 15 mm for LCS and BS,
respectively. The stent length for LCS was 19.7 mm and for
BS 17.7 mm in vessels with a diameter of 3.5 mm.
Angiographic control was performed using a 4 F diagnostic
catheter after implantation. After catheter retrieval, the femoral
artery was ligated, and the animals allowed to recover.
Follow-up controls were conducted at 3 days (subacute)
and 28 days (mid-term) to assess blood and vessel responses
(Fig. 2).
2.2.1 Subacute follow-up at day 3
After surgical exposure of the left carotid artery, a 4 F
sheath was placed distal to the stent for retrograde digital
subtraction angiography (DSA) of all three vessels. A ret-
rograde approach was performed due to the limited arterial
accesses. Following angiography, the left CCA with the
stent was resected for histological analysis. The artery was
ligated proximally, and the animals allowed to recover.
2.2.2 Mid-term follow-up at day 28
DSA of the two remaining stents was performed using a 4 F
sheath placed in the right femoral artery, as described above
for day 3. Animals were subsequently euthanized via lethal
injection of pentobarbital and vessels removed for histology.
Fig. 1 Schematic drawing of the positioning of the three stents in the
common carotid artery, the subclavian artery, and the abdominal aorta.
a Picture of the two analysed stents: braided Accero® (top) and laser-
cut Acclinoflex®/Credo® (bottom)
Fig. 2 Unsubtracted angiograms of the left common carotid artery (CCA) (a, b) and subclavian artery (SA) (c, d) implanted in a retrograde fashion
through a sheath (dashed arrow). White arrowheads highlight stent markers
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For stents inserted in the SA and the AA, diameter
measurement was performed directly before and after stent
implantation, on day 3, and on day 28. Removed specimens
were fixed in formalin for histological analysis.
3 Data analyses
3.1 Angiographic evaluation
Vessel diameters in the middle section of the stents obtained
from the DSA were evaluated by three experienced inter-
ventional neuroradiologists (RMB, UY, AS) on consensus
in posterior-anterior projection using the post-processing
software OsiriX (Pixmeo, Switzerland). The vessel diameter
was averaged for each vessel, stent type, and follow-up
time, including before implantation, on day 3, and on day
28 s (the latter only for the SA and the AA). Patency of the
branch arteries covered by the devices was also assessed at
follow-up.
3.2 Histopathology
Histopathological processing and histomorphometry are
described in the Supplementary material. Analysis of the
subclavian arteries and aorta included leukocyte and giant
cell counts, dehiscence, media layer compression, and in-
stent thrombosis. Due to the earlier explantation time, CCA
analysis focused on fresh and residual thrombi in the vessel
wall, the presence of thrombotic material surrounding stent
struts, and in-stent thrombosis.
3.3 Statistical analyses
Statistical analysis was performed using GraphPad Prism
(version 6.01, GraphPad Software, U.S.A.). Data for the
two groups were analysed with an unpaired Student’s t test.
One-way ANOVA with Holm-Sidak´s post hoc correction
was used for comparisons of more than two groups. Con-
tinuous variables are expressed as means and standard
deviations. A paired t test was used to determine the sig-
nificance of any difference in the changes within each
group. A two-sided P ≤ 0.05 was statistically significant.
4 Results
4.1 Angiographic evaluation
Stent delivery and deployment was successful in all twelve
rabbits. No cases of stent migration were observed. There
was no stenosis or in-stent thrombosis during follow-up for
both stent types. Branch artery occlusion was not observed.
Average vessel diameter before stent implantation and at
follow-up times as well as the percentage increase relative
to pre-implantation time are shown in Table 1.
There was a trend toward a progressive increase of vessel
diameter in all arteries during follow-up, except for the SA
with the LCS between days 3 and 28. BS were observed to
generally result in greater vessel lumen increase over the
follow-up period for all arteries compared to LCS (Table 1).
The maximum vessel diameter increase following BS
insertion was observed in the SA at 28 days follow-up in
contrast to the CCA at 3 days follow-up. Furthermore,
vessel lumen increase was significantly higher in the CCA
and SA compared to the AA at 3 and 28 days follow-up,
respectively (P= 0.006 and P= 0.0039) (Table 1 and
Fig. 3). For LCS, a maximum vessel diameter increase of
6% was observed after implantation in the CCA at 3 days
follow-up.
4.2 Histomorphology
In both the AA and SA, there was no significant difference
in the maximum neointimal thickness between the two
groups (P= 0.085, P= 0.027) (Fig. 4). Comparison of the
BS and LCS types only revealed a significantly higher
vessel lumen diameter (P= 0.0002) and lumen patency
(P= 0.0014) in the SA.
4.3 Histopathology at day 3 (CCA)
At day 3, thrombus material was found in the strut regions
of the explanted devices (Table 2 and Fig. 5), with a
Table 1 Angiographic measurement of vessel diameter and
progressive vessel lumen increase
Follow-up Carotid artery Subclavian artery Abdominal aorta
Laser cut stent (LCS)
Vessel lumen diameter (mm)
Before impl. 1.92 ± 0.19 1.92 ± 0.21 3.50 ± 0.33
Day 3 2.03 ± 0.23 2.00 ± 0.22 3.52 ± 0.34
Day 28 – 2.00 ± 0.22 3.55 ± 0.26
Vessel lumen dimeter increase (%)
Day 3 6.0% 4.4% 0.5%
Day 28 4.4% 1.6%
Braided stent (BS)
Vessel lumen diameter (mm)
Before impl. 1.88 ± 0.23 1.97 ± 0.16 3.53 ± 0.37
Day 3 2.08 ± 0.12 2.12 ± 0.15 3.57 ± 0.35
Day 28 2.20 ± 0.11 3.60 ± 0.32
Vessel lumen diameter increase (%)
Day 3 11.6% 7.8% 1.0%
Day 28 12.4% 2.1%
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considerably higher frequency in BS compared to LCS.
Adherent clot material was observed in 100% of the BS
structs compared to 58% of LCS struts. Residual thrombi
were found in three BS within the clot and were in direct
contact with the strut surface. A thrombus in the lumen was
present in one stent in the LCS group, with focal vessel wall
contact containing an extensive accumulation of fresh ery-
throcyte. A residual thrombus was not observed within the
vessel wall.
4.4 Histopathology at day 28 (AA and SA)
Dehiscence was frequently observed and usually com-
menced in the stent strut region, developing at the interface
between the neointima and the media layer, and, in some
cases, into the media to the media-adventitia border. In the
AA, dehiscences (both focal and widespread) were
observed in only one vessel with an LCS compared to 5 of 6
Fig. 3 Percentage of increase in vessel diameter at 3 days (a) and
28 days (b) of follow-up. In the case of BS implantation, there was a
significantly higher diameter increase in the common carotid artery
(CCA) compared to the abdominal aorta (AA) after 3 days (**P=
0.006) as well as in the subclavian artery (SA) compared to the
abdominal aorta (AA) after 28 days (**P= 0.0039)
Fig. 4 Histomorphological analysis of neointimal thickness (a, d),
vessel lumen (b, e), and lumen patency ratio (c, f) for the abdominal
aorta (AA) and subclavian artery (SA) at 28 days follow-up, showing a
significantly higher lumen diameter (***P= 0.0002) and patency
(**P= 0.0014) for braided stents in the SA
Table 2 Histopathology of the left carotid artery at day 3
Left carotid artery (day 3)
LCS BS
Struts with clot material 58% 100%
Fresh thrombus 0 0
Residual thrombus 0 3 (within clot)
Thrombus within the lumen 1 0
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vessels treated with BS. In the SA, dehiscence was present
in all vessels and was widespread in three LCS and five BS.
Inflammation and foreign body reactions were rare
(Table 3), with only one lymphocyte found in a BS
implanted in the AA and one giant cell in an LCS inserted
in the SA. In both groups, media compression was present
in all samples.
5 Discussion
The present study reports the first systematic in vivo com-
parison of two main neurovascular stent systems, LCS and
BS. Despite the expanding use of flow diverters, which
reconstruct the lumen through flow modulations, stents can
still provide coil support in wide-necked aneurysms, with a
considerably lower metal coverage than that in flow diver-
ters, therefore potentially resulting in fewer thromboem-
bolic complications.
Various clinical studies have investigated both BS and
LCS [8–11]. The risk of thromboembolic complications
related to both stent types ranges between 4 and 8%
[12–14]. However, there is very little data available com-
paring the two technologies within the framework of an
experimentally [15, 16]. Concurrently, studies on in vivo
animal models of neurovascular stents are rare. Krings et al.
[17] compared different approaches to treat cerebral
aneurysms in created aneurysms in 30 rabbits using porous
LCS, covered stents (polyurethane shore 60 D), and stent
(porous LCS) assisted coiling. At a follow-up time of 3 and
6 months. They observed a higher aneurysm occlusion rate
in the covered stent group compared to both groups treated
with porous stents, with and without coils. Moreover, while
covered stents presented a mild neointima thickening and
one parent vessel occlusion (10%), in-stent-stenosis was
more frequent in porous stents, amounting up to 40%.
Another study group investigated the alteration of blood
flow dynamics after FD and laser-cut stent implantation in
the rabbit aneurysm model. They observed prolonged blood
stagnation in the aneurysm sac in the FD group [18].
However, the appearance of thrombus formation or
inflammatory reactions was not assessed when comparing
Fig. 5 Representative
histological images of a
transverse section of a laser-cut
stent (LCS; a) and a braided
stent (BS; b) in the subclavian
artery at 3 days and 28 days
follow-up (c, d). An asterisk
shows thrombus formation.
White arrows show compression
of elastic fibres in the tunica
media. Representative
histological images of a
transverse section of an LCS (e)
and a BS (f) in the subclavian
artery at 28 days follow-up
showing intimal hyperplasia.
# shows the neointima
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the different stent types in vivo. In both studies, follow up
times between 1 and 6 months addressed middle term vessel
reaction, while acute vessel injury and thrombosis were not
mattered of investigation.
The present study focused on biocompatibility with
regard to blood and vessel responses, comparing the two
stent technologies in a rabbit model. To achieve this, a
worst-case animal model was used, with stent implantation
in small arteries without antiplatelet therapy. This scenario
represents a critical condition, potentially provoking further
thromboembolic and inflammatory reactions to facilitate a
comparison of the two stent groups.
Explanting of the CCA after 3 days and both the AA and
SA after 28 days enabled two follow-up periods in the same
animal, reducing the number of animals sacrificed. Both
follow-up times were selected with the expectation of
observing acute reactions at day 3 post-implantation as well
as neointimal thickness at day 28. Interestingly, neointimal
thickness was well developed and did not increase con-
siderably beyond the highest level observed after one
month, as previously reported [19, 20].
There was no concern about angiographic parent vessel
and branch artery patency. In-stent thrombosis and stenosis
were not observed at angiographic follow-up. Moreover,
vessel diameter measurements showed enlargement in all
vessels at almost all times, which was not significant. In
comparison to pre-implantation values, this enlargement
was considerably higher for BS compared to LCS,
exceeding 10% in the CCA at 3 days (12.4%) and in the SA
at 28 days (11.6%). Considering the reciprocal and dis-
proportionate relationship between vessel resistance and the
diameter, the maximum measured enlargement of 12.4%
would lead to a decrease in blood flow resistance to ~60%.
However, it remains unknown whether this decrease in
resistance has the potential to impact blood flow in vessels
in clinical conditions, since the flow rate results from
numerous serial vascular resistances, with the stented vessel
region representing a short part en route to the brain.
Although the study did not include a control group without
stent implantation, the considerable vessel enlargement
observed on day 3 implied that this effect was growth-
dependent.
Histomorphology showed a significantly greater lumen
diameter in the SA treated with a BS compared to LCS,
confirming angiographic measurements. Interestingly, the
patency ratio was also significantly higher in BS. However,
this observation was attributable primarily to the greater
vessel enlargement and not to neointimal formation, which
was comparable in both groups. Furthermore, the absolute
vessel diameter values measured by histomorphological
evaluation were considerably smaller than those measured
in angiography in both the SA and the AA. This dis-
crepancy could be based on vessel behaviour during the
explanation phase, potentially attributable to shrinkage due
to intraluminal pressure reduction or spastic reaction.
After 28 days, considerable inflammation and foreign
material reactions in stented vessels were not observed
histopathologically. Correspondingly, only two vessels
demonstrated a mild reaction. The media layer was com-
pressed in all samples, with no clear differentiation between
the two groups. The most pronounced effect observed at the
longer follow-up period was the presence of dehiscence,
which emerged in the strut region. This effect appears most
pronounced in BS in both the SA and the AA. The reason
for this finding remains open to debate; however, the
interplay of wire movement could cause a paucity of cells in
place of tissue in the region close to the wires. Furthermore,
different expanding force and frictional actions of the
structure relative to the vessel wall could affect cell pro-
liferation and extracellular matrix formation. Since both
stunt devices have a similar electropolished surface, we do
not believe there is a biochemical reaction at the surface that
is attributable to this phenomenon.
One vessel was explanted per animal 3 days after stent
implantation. This was performed because an acute tissue
response can also be potentially responsible for further
priming the thromboinflammatory cascade, and, therefore,
tissue appearance [21, 22]. The presence of thrombi at the
stent differed between the LCS and BS types. All stent
struts presented an adherent thrombus in the BS group
compared to the LCS group (58%). Moreover, a residual
thrombus at the interface between the material and the
thrombus was observed in three specimens in BS, sug-
gesting an endothelial cell injury as a potential cause for
thrombi formation. Mechanisms of thrombus formation
have been proposed to include fluid dynamic disturbance
with blood stagnation as well as high shear stress areas [23],
which could be pronounced in BS because of their higher
profile at the intersection between two wires. Finally, the
combination of tissue damage, blood stagnation, and blood-
material contact can lead to acute thrombosis.
This study has several limitations. One primary limita-
tion concerns the size of the stunts, which differed in the SA






LCS BS LCS BS
Inflammatory cells 0 1 0 0
Giant cells 0 0 1 0
Media compression all all all all
Dehiscence (only focal) 0 2 3 1
Dehiscence (widespread) 1 3 3 5
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for both stents. A smaller BS with a diameter of 2.5 mm was
selected because of the identical number of cells (6) along
the stunt circumference than an LCS with a diameter of
4.5 mm. Stent dimensions affect foreshortening as well as
radial force on the vessel wall. Regardless of the dimen-
sions, an identical mechanical behaviour cannot be ensured,
particularly because of the higher axial compressibility of a
BS. Therefore, stents were implanted with similar geome-
trical characteristics. Another limitation is the lack of ran-
domization and non-blinded nature of the study.
Furthermore, only the middle section of each stent was
considered for histopathological analysis, neglecting
potential effects at the stent ends. Finally, the constitution
and surrounding tissue of rabbit extracranial vessels differ
from that of human intracranial vessels. In particular, the
SA is highly exposed to leg movement in the rabbit, pre-
sumably producing more mechanical solicitations than
vessels in the intracranial space.
6 Conclusion
A systematic comparison of two neurovascular stent tech-
nologies was performed in a new animal model in the
absence of antiplatelet therapy, including two histological
follow-up times (at days 3 and 28). No stenosis or in-stent
thrombosis was detected during follow-up for both stent
types. Angiography revealed a more marked vessel size
enlargement in the BS compared to the LCS at both follow-
ups, which was confirmed by histomorphological analysis
at 28 days. Thrombus formation was pronounced on BS
wires than on LCS struts on day 3, which failed to result in
thrombosis or increased neointimal thickness on day 28.
The results support the understanding of device and vessel
responses and demonstrated the feasibility of a model that
facilitates further investigations into neurovascular tech-
nologies in the future.
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